Our findings demonstrated that sesamol decreased the expression of SREBP-1c and increased the expressions of p-HSL, PGC1α, and CPT1α, which promoted lipid metabolism in the liver to ameliorate obesity and obesity-associated metabolic disorders. The gene discussed is SREBF1; the disease is metabolic disease.